Watch Ticker

Tourmaline Bio, Inc. Common Stock

Go to Tourmaline Bio, Inc. Common Stock Website

$21.40

-1.02 (-4.55%)

Live

Previous Close

$21.94

Day Range

$21.64 - $22.305

Previous Day Range

$21.51 - $22.93

Market Cap

$575.9 million USD

Day Vol.

184377

Previous Day Vol.

135584

Currency

USD

Primary Exchange

None

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Thyroid Eye Disease Market to Accelerate Substantially by 2034, Assesses DelveInsight | Key Companies Developing ... - GlobeNewswire

The thyroid eye disease market is expected to show good positive growth by 2034, driven by new product launches, a robust pipeline of emerging therapies, and an increase in the geriatric population.

Related tickers: VRDN, RHHBY, IMVT, AMGN, SLRN, TRML.

Read Full Article

Tourmaline Bio, Inc. - Tourmaline Bio Announces the Promotion of Ryan Robinson to Chief Financial Officer

Tourmaline Bio Announces the Promotion of Ryan Robinson to Chief Financial Officer

Related tickers: TRML.

Read Full Article

Trending Tickers

Please sign in to view